Research conducted by:
RAND Justice, Infrastructure, and Environment;
RAND Institute for Civil Justice
Journal Articles (9)
n the United States, drugs are jointly regulated by the US Food and Drug Administration, which oversees premarket clinical trials designed to ensure drug safety and efficacy, and the liability system, which allows patients to sue manufacturers for unsafe drugs. In this paper, the authors examine the potential welfare effects of this dual system to ensure the safety of medical products, and conclude that product liability exemptions for FDA regulated activities could raise economic efficiency.
Framing the Compensation Inquiry
The authors addressed research questions regarding the efficacy of herbal ephedra and ephedrine for weight loss and athletic performance.
In this paper, the authors attempt to develop information about a narrow but important piece of a very complex puzzle -- the sketchy economic effects of product liability.
For product liability verdicts during 1983 to 1996 involving automobile manufacturers, the authors examine the amount of coverage in several dozen newspapers.
The real world of tort litigation
This article aims to help readers think systematically about the economic effects of product liability and punitive damages.
A content analysis of 249 articles from Time, Newsweek, Fortune, Forbes, and Business Week during 1980-1990 examined the representativeness of popular media coverage of tort litigation.
The civil justice system has not responded well to the challenge of handling mass torts, and many innovations have been proposed to improve processing of these cases.